This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Aasen AO, Ohlsson K, Larsbraaten M, Amundsen E (1978) Changes in plasminogen levels, plasmin activity and activity of antiplasmin during endotoxin shock in dogs. Eur Surg Res 10: 63–72
Aasen AO, Dale J, Ohlsson K, Gallimore M (1978) Effects of slow intravenous administration of endotoxin on blood cells and coagulation in dogs. Eur Surg Res 10:194–205
Aasen AO, Smith-Erichsen N, Amundsen E (1985) Studies on pathological plasma proteolysis in patients with septicemia. Scand J Clin Lab Invest [Suppl 178] 45: 37–45
Addis T (1948) Glomerular nephritis. MacMillian, New York
Ambruso DR, Durante DP, Mcintosh RM, Hathaway WE (1977) Factor VIII and renal disease. Ann Intern Med 87: 636–637
Amery AH, Pegrum GD, Risdon RA, Williams G (1973) Nature of hyperacute (accelerated second set) rejection in dog renal allografts and effects of heparin on rejection process. Br Med J I: 455–458
Anderson M, Dewar P, Fleming LB et al. (1974) A controlled trial of dipyridamole in human renal transplantation and an assessment of platelet function studies in rejection. Clin Nephrol 2: 93–99
Andrassy K (1979) Nephrologie and Hämostase. Aktuel Nephrol 12: 635–647
Andrassy K, Ritz E (1985) Uremia as a cause of bleeding. Am J Nephrol 5: 313–319
Andrassy K, Buchholz L, Bleyl U, Ritz E, Seidel D (1976) Topography of human urokinase activity in renal tissue. Nephron 16: 213–219
Andrassy K, Koderisch J, Fritz S, Bechtold H, Sonntag H (1986) Alteration of hemostasis associated with cefoperazone treatment. Infection 14: 27–31
Angles-Cano E, Rondeau E, Delarue F, Hagege J, Sultan Y, Sraer JD (1985) Identification and cellular localization of plasminogen activators from human glomeruli. Thromb Haemost 54: 688–692
Arskog D, Aksnes L, Lehman V (1980) Low 1,25 dihydroxyvitamin D in heparininduced osteopenia. Lancet II: 650–651
Atkinson K, Biggs JC, Hayes J, Ralston M, Dodds AJ, Concannon AJ, Naidoo D (1983) Cyclosporin A associated nephrotoxicity in the first 100 days after allogeneic bone marrow transplantation: three distinct syndromes. Br J Haematol 54: 59–67
Avioli L (1975) Heparin induced osteopenia, a reappraisal. Adv Exp Med 52: 375–387
Aviram M, Rosenblat M, Potesman M, Dankner G, Brook JG (1986) Plasma lipoprotein and platelet function after heparin injection: studies in normal fasted and postprandial and in type V hyperlipoproteinemic subjects. Biochem Med Metab Biol 35: 279–292
Bachmann F, Ing TS, Sagartz S (1975) Hyperkoagulabilität und kompensierte intravaskuläre Gerinnung bei chronischer Niereninsuffizienz und nach Nierentransplantation. Schweiz Med Wochenschr 105: 1771–1773
Bagdade JD (1980) Accelerated atherosclerosis in patients on maintenance dialysis. Year Book Medical Publishers, Chicago, pp 7–21
Barksdale B, Henson EC, Brunson JG (1970) Effects of epinephrine on the generalized Shwartzman reaction. Arch Pathol Lab Med 89: 259–265
Barnes AD, Coles GA, White HJO (1974) A controlled trial of anticoagulants in cadaveric renal transplantation. Transplantation 17: 491–494
Bartheis M, Poliwoda H (1980) Gerinnungsanalysen. Thieme, Stuttgart
Barzu T, Molho P, Tobelem G, Petitou M, Caen JP (1984) Binding of heparin and low molecular weight heparin fragments to human vascular endothelial cells in culture. Nouv Rev Fr Hematol 26: 243–247
Baumgartner HR, Tschopp TB (1977) Platelet mediated vasoconstriction: evidence in vivo. Thromb Haemost 38: 186
Behring-Werke (1979) Großer Gerinnungsstatus. Behringwerke, Frankfurt am Main
Bemis J, Rigney J, Sosin A, Deane N (1977) Enhanced platelet aggregation in chronic renal failure patients receiving hemodialysis treatment. Trans Am Soc Artif Intern Organs 23: 48–51
Bengtsson G, Olivecrona R, Hok M, Riesenfeld J, Lindahl U (1980) Interaction of lipoprotein lipase with native and modified heparin-like polysaccharides. Biochem J 189: 625–633
Bennett NB, Ogston D (1970) Inhibitors of the fibrinolytic enzyme system in renal disease. Clin Sei 39: 549–557
Bennett NB, Ogston D, Crawford GPM, Douglas AS (1973) The fibrinolytic enzyme system in hypertension. J Clin Pathol 26: 351–353
Bennett NM, Bennett D, Holland NH, Luke RG (1972) Serum fibrin degradation products in the diagnosis of transplantation rejection. Transplantation 14: 311–316
Bergquist D, Bergentz SE, Bornmyr S, Husberg B, Konrad P, Ljungner H (1985) Deep vein thrombosis after renal transplantation: a prospective analysis of frequency and risk factors. Eur Surg Res 17: 69–74
Bergstein JM, Michael AF (1972) Cortical fibrinolytic activity in normal and diseased human kidneys. J Lab Clin Med 79: 701–709
Bergstein JM, Hoyer JR, Michael AF (1974) Glomerular fibrinolytic activity following endotoxin-induced glomerular fibrin deposition in the pregnant rat. Am J Pathol 75: 195–199
Berkada B, Akokan, G, Derman U (1971) Fibrinolytic response to physical exercise in males. Atherosclerosis 13: 85–91
Bernik MB (1973) Increased plasminogen activator (urokinase) in tissue culture after fibrin deposition. J Clin Invest 52: 823–834
Bernik MB, Kwaan HC (1969) Plasminogen activator activity in cultures from human tissues. An immunological and histochemical study. J Clin Invest 48: 1740–1753
Bertele V, Roncaglioni ML, Donati MB, de Gaetano G (1983) Heparin counteracts the antiaggregating effect of prostacyclin by potentiating platelet aggregation. Thromb Haemost 49: 81–83
Bick RL, Diekes ML, Wilson WL, Fekete LF (1977) Antithrombin III (AT III) as a diagnostic aid in disseminated intravascular coagulation. Thromb Res 10: 721–729
Binnema DJ, Iersel JJL van, Dooijewaard G (1986) Quantification of urokinase antigen in plasma and culture media by use of an elisa. Thromb Res 43: 569–577
Blarney RW, Renney JTG, Baxter TY, Deans BJ (1973) The use of 125J-fibrinogen in the detection of renal allograft rejection. Transplantation 16: 5–8
Blauhut B, Kramar H, Vinazzer H, Bergmann H (1985) Substitution of antithrombin III in shock and DIC: a randomized study. Thromb Res 39: 81–89
Bleyl U, Kuhn W, Graeff H (1969) Retikuloendotheliale Clearance intravasaler Fibrinmonomere in der Milz. Thromb Diath Haemorrh 22: 87–100
Boehmig HJ, Giles GR, Amemiya H et al. (1971) Hyperacute rejection of renal homografts: with particular reference to coagulation changes, humoral antibodies and formed blood elements. Transplant Proc 3: 1105–1116
Böhmig HJ (1971) Untersuchungen zur Pathogenese der hyperakuten Abstoßung von Homo- und Heterotransplantaten der Niere beim Hund. Wien Klin Wochenschr 24: 429–436
Boneu B, Durand D, Counillon F, Charlet JP, Bierme R, Sue JM (1978) Increased level of factor VIII complex in severe arterial hypertension. Haemostasis 7: 332–338
Bonser RS, Adu D, Franklin I, McMaster P (1984) Cyclosporin-induced haemolytic uraemic syndrome in liver allograft recipient. Lancet II: 1337
Brandt P, Jespersen J, Sorensen LH (1981) Antithrombin III and platelets in haemodialysis patients. Nephron 28: 1–3
Breddin HK (1986) Akute und chronische Verbrauchskoagulopathie und Nierenerkrankungen. Nieren Hochdruckkr 15: 344–349
Brennan TG, Giles GR, Rajah SM, Davison AM, Guillou PJ (1977) Coagulation changes in sensitized canine renal allografts. Br J Surg 64: 15–22
Brown JE, Baugh RF, Hougie C (1979) Effect of exercise on the factor VIII complex: a correlation of the von Willebrand antigen and factor VIII coagulant antigen increase. Thromb Res 15: 61–67
Brown PM, Johnston KW, Fenton SSA, Cattran DC (1981) Symptomatic exacerbation of peripheral vascular disease with chronic ambulatory peritoneal dialysis. Clin Nephrol 16: 258–261
Brown Z, Neild GH, Willoughby JJ, Somia NV, Cameron SJ (1986) Increased factor VIII as an index of vascular injury in cyclosporine nephrotoxicity. Transplantation 42: 150–153
Broyer M, Brunner FP, Brynger H et al.(1982) Combined report on regular dialysis and transplantation in Europe. Proc Eur Dial Transplant Assoc Eur Ren Assoc 19: 2–59
Broze GJ Jr (1982) Binding of human factor VII and Vila to monocytes. J Clin Invest 70: 526–535
Buluk K, Furman M (1962) On the controlling function of the kidneys in fibrinolysis. Experientia 18: 146–147
Busch GJ, Martins ACP, Hollenberg NK, Wilson RW, Colman RW (1975) A primate model of hyperacute renal allograft rejection. Am J Pathol 79: 31–56
Busch GJ, Kobayashi K, Hollenberg NK, Birtch AG, Colman RW (1975) Hyperacute renal allograft rejection in the primate. Am J Pathol 80: 1–19
Busch GJ, Martins ACP, Hollenberg NK, Moretz RC, Wilson RE, Colman RW (1976) Successful short-term modification of hyperacute renal allograft rejection in the primate. Am J Pathol 82: 43–60
Cade JF, Buchanan MR, Boneu B, Ockelford P, Carter CJ, Cerskus AL, Hirsh J (1984) A comparison of the antithrombotic and haemorrhagic effects of low molecular weight heparin fractions: the influence of the method of preparation. Thromb Res 35: 613–625
Camussi G (1986) Potential role of platelet-activating factor in renal pathophysiology. Kidney Int 29: 469–477
Canavese C, Stratta P, Pacitti A et al. (1982) Impaired fibrinolysis in uremia: partial and variable correction by four different dialysis regimes. Clin Nephrol 17: 82–89
Capitanio A, Mannucci PM, Ponticelli C, Pareti F (1982) Detection of circulating released platelets after renal transplantation. Transplantation 33: 298–301
Carlsen E, Courillon-Mallet A, Prydz H (1985) Effect of cyclosporin A on procoagulant activity in mononuclear blood cells and monocytes in vitro. Clin Exp Immunol 60: 407–416
Carter CJ, Kelton JG, Hirsh J, Gent M (1981) Relationship between the antithrombotic and anticoagulant effects of low molecular weight heparin. Thromb Res 21: 169–174
Carter CJ, Kelton JG, Hirsh J, Santos AV, Gent M (1982) The relationship between the hemorrhagic and antithrombotic properties of the low molecular weight heparin in rabbits. Blood 59: 1239–1245
Carvalho AC A (1983) Bleeding in uremia-a clinical challenge. N Engl J Med 308: 38–39
Carvalho JS, Carvalho ACA, Vaillancourt RA, Page LB, Colman RW, Landwehr DM, Oken DE (1978) The pathogenetic significance of intravascular coagulation in experimental acute renal failure. Nephron 22: 484–491
Cash JD, Woodfield DG (1968) Fibrinolytic response to moderate exercise in 50 healthy middle-aged subjects. Br Med J II: 658–661
Cash JD, Woodfield DG, Allan AGE (1970) Adrenergic mechanisms in the systemic plasminogen activator response to adrenaline in man. Br J Haematol 18: 487–494
Castaldi PA, Rozenberg MC, Stewart JH (1966) The bleeding disorder of uraemia: a qualitative platelet defect. Lancet II: 66–69
Charytan C, Purtilo D (1969) Glomerular capillary thrombosis and acute renal failure after epsilon-amino caproic acid therapy. N Engl J Med 280: 1102–1104
Cheney K, Bonnin JA (1962) Haemorrhage, platelet dysfunction and other coagulation defects in uraemia. Br J Haematol 8: 215–222
Cheung AK, Henderson LW (1986) Effects of complement activation by hemodialysis membranes. Am J Nephrol 6: 81–91
Clark J, Hochman R, Rolla AR, Thomas S, Miller DG, Kaldany A, Délia JA (1983) Coagulopathy associated with the use of cephalosporin or moxalactam antibiotics in acute and chronic renal failure. Clin Exp Dial Apher 7: 177–190
Clarkson AR, MacDonald MK, Fuster V, Cash JD, Robson JS (1970) Glomerular coagulation in acute ischaemic renal failure. Q J Med 39: 585–599
Clarkson AR, Morton JB, Cash JD (1970) Urinary ftbrin/fibrinogen degradation products after renal homotransplantation. Lancet II: 1220–1225
Clauss A (1957) Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 17: 237–246
Clyne DH, Kincaid-Smith P, Ribush NT, Morris PJ, Marshall VC (1970) Improvement in renal blood flow of rejecting renal allografts during heparin infusion. Med J Aust 1:522–524
Cochran M, Lawton S, Rowlands LM (1979) Fibrinous pericaditis and fibrinolysis in chronic dialysis patients. Clin Nephrol 11: 23–25
Cohen BD, Patel H, Kornhauser RS (1977) Alternate reasons for atherogenesis in uremia. Proc Dial Transplant Forum 7: 178–180
Cole EH, Cardella CJ, Schulman J, Levy GA (1985) Monocyte procoagulant in activity and plasminogen activator. Transplantation 40: 363–371
Collen D (1980) Natural inhibitors of fibrinolysis. J Clin Pathol [Suppl 14] 33: 24–30
Collen D, Lijnen HR (1986) The fibrinolytic system in man. CRC Crit Rev Oncol Hematol 4: 249–301
Collen D, Schetz J, De Cock F, Holmer E, Verstraete M (1977) Metabolism of antithrombin III in man: effects of venous thrombosis and of heparin administration. Eur J Clin Invest 7: 27–35
Colman RW (1984) Surface-mediated defense reactions. The plasma contact activation system. J Clin Invest 73: 1249–1253
Colman RW, Schmaier AH (1986) The contact activation system: biochemistry and interactions of these surface-mediated defense reactions. CRC Crit Rev Oncol Hematol 5: 57–85
Colman RW, Wong PY (1977) Participation of hageman factor dependent pathways in human disease states. Thromb Haemost 38: 751–775
Colman RW, Braun WE, Busch GJ, Dammin GJ, Merrill JP (1969) Coagulation studies in the hyperacute and other forms of renal-allograft rejection. N Engl J Med 281:685–691
Colman RW, Habal M, Hollenberg NK, Birtch AG, Busch GJ (1976) Hyperacute renal allograft rejection in the primate. Am J Pathol 82: 25–42
Colwell JA (1986) Effects of exercise on platelet function, coagulation, and fibrinolysis. Diab Metab Rev 1: 501–512
Corda R, Alberti M, Cacocci L, Putzolu G, Mannucci PM (1979) An increased factor VHI-antigen as an indicator of endothelial damage in measles. Thromb Res 14:805–810
Cosgriff SW (1951) Thromboembolic complications associated with ACTH and cortisone therapy. JAMA 147: 924–926
Crawford GA, Sardie E, Stewart JH (1979) Heparin-released plasma lipases in chronic renal failure and after renal transplantation. Clin Sei 57: 155–165
Crisnic I, Cucuianu M, Manasia M, Uza G (1971) Disseminated intravascular coagulation and acute renal failure. Thromb Diath Haemorrh 26: 332–340
Date A, Pulimood R, Jakob CK, Kirubakaran MG, Shastry JCM (1986) Haemolytic-uraemic syndrome complicating snake bite. Nephron 42: 89–90
Davies JWL, Liljedahl S-O, Reizenstein P (1970) Fibrinogen metabolism following injury and its surgical treatment. Injury 1:178–185
Davis GL, Abildgaard CF, Bernauer EM, Britton M (1976) Fibrinolytic and haemostatic changes during and after maximal exercise in males. J Appl Physiol 40: 287–291
Delvos U, Müller-Berghaus G (1985) Die Bedeutung des Endothels der Gefäßwand für die Aufrechterhaltung der Hämostase. Klin Wochenschr 63:1237–1246
Denson KWE (1977) The ratio of factor Vlll-related antigen and factor VIII biological activity as an index of hypercoagulability and intravascular clotting. Thromb Res 10: 107–119
Deykin D (1983) Uremic bleeding. Kidney Int 24: 698–705
Diehm C, Moerl H, Schettler G (1984) Beeinflussung von Blutgerinnung und Fibrinolyse durch körperliche Aktivität. Klin Wochenschr 62: 299–302
Docci D, Turci F, Del Vecchio C, Bilancioni R, Cenciotti L, Pretolani E (1984) Hemodialysis - associated platelet loss: study of the relative contribution of dialyzer membrane composition and geometry. Int J Artif Organs 7: 337–340
Dooijewaard G, Tersel JJL van, Los P, Kluft C (1983) The intrinsic system of fibrinolysis: identification and partial purification of plasma urokinase. In: Davidson JF, Bachmann F, Bouvier CA, Kruithof EO (eds) Progress in fibrinolysis VI. Churchill Livingstone, Edinburgh London Melbourne New York, pp 46–49
Drannik GN, Yena YM (1979) Hemocoagulation disorders in kidney allotrans-plants, caused by preformed antirenal antibodies. Thromb Res 16: 527–536
Drommer R, Merten HA, Stankovic P, Köstering H (1984) Instillation von Heparin-Antithrombin III-Lösungen zur Verbesserung der Transplantationserfolge bei mikrovaskulär anastomisierten Unterarmlappen. In: Köstering H (Hrsg) Antithrombin III. Schattauer, Stuttgart S 185–190
Drukker W (1978) Haemodialysis: A historical review. In: Drukker W, Parsons M, Mäher JF (eds) Replacement of renal function by dialysis. Nijhoff, Dordrecht, pp 3–37
Dunn FW, Soria C, Thomaidis A, Soria J, Dupuy E, Bellucci S, Tobelem G (1984) Interaction of platelets with standard heparin and low molecular weight fractions. Nouv Rev Fr Hematol 26: 249–253
Dyck RF, Kappell JE, Sheridan D, Card RT (1986) Reversible cyclosporine-associated hemolytic uremic syndrome in a renal transplant recipient: a role for a platelet aggregating factor? Transplant Proc 18: 228–229
Edward N (1973) Fibrinolysis in patients on regular hemodialysis. Clin Nephrol 1: 97–100
Egbring R (1984) Erworbene Gerinnungsstörungen bei Patienten mit internistischen Erkrankungen. Med Welt 35: 1433–1437
Egbring R, Seitz R, Burghard R, Wolf M (1987) Gerinnungsstörungen bei Infektionen und Sepsis. In: Mammen EF (Hrsg) Intensivmedizin aktuell. Medizinische Verlagsgesellschaft, Marburg, S 81–98
Eika C (1972) On the mechanism of platelet aggregation induced by heparin, protamine, and polybrene. Scand J Haematol 9: 248–257
Eknoyan G, Wacksman SJ, Glueck HJ, Will JJ (1969) Platelet function in renal failure. N Engl J Med 280: 677–681
Erickson LA, Schleef RR, Ny T, Loskutoff DJ (1985) The fibrinolytic system of the vascular wall. Clin Haematol 14: 513–530
Erickson RV, Williman M, Pendras JP (1966) A true hypercoagulability state in patients on chronic hemodialysis. Trans Am Soc Artif Intern Organs 12: 205–206
Everett MM, Emerson TE (1984) Antithrombin III (ATIII) increase survival and diseases mortality during endotoxin shock in the rat. Circ Shock 13: 29
Ferguson EW, Guest NM (1974) Exercise, physical conditioning, blood coagulation and fibrinolysis. Thromb Diath Haemorrh 31: 63–71
Forbes CD (1981) Thrombosis and artificial surfaces. Clin Haematol 10: 653–668
Forbes CD, Pensky J, Ratnoff OD (1970) Inhibition of activated hageman factor and activated plasma thromboplastin antecedent by purified serum CI inactivator. J Lab Clin Med 76: 809–815
Frampton G, Parbtani A, Marchesi D, Duffus P, Livio M, Remuzzi G, Cameron JS (1983) In vivo platelet activation with in vitro hyperaggregability to arachidonic acid in renal allograft recipients. Kidney Int 23: 506–513
Friberger P (1982) Chromogenic peptide substrates. Scand J Clin Lab Invest [Suppl 162] 42: 1–298
Friberger P, Gallimore MJ (1986) Activation of fibrinolysis. In: Köstering H, Kreuzer H, Neuhaus KL (Hrsg) Thrombolytische Therapie des akuten Myokardinfarktes. Schattauer, Stuttgart, S 21–26
Fuchs U, Graff J (1986) Gefaßwand und Fibrinolyse. Pathologische Aspekte. Folia Haematol 113: 176–183
Fuster V, Bowie EJW, Lewis JC, Fass DN, Owen CI Jr, Brown AL (1978) Resistance to arteriosclerosis in pigs with von Willebrand disease. J Clin Invest 61: 722–730
Gader AMA, Clarkson AR, Cash JD (1973) The plasminogen activator and coagulation factor VIII responses to adrenaline, noradrenaline, isoprenaline and salbutamol in man. Thromb Res 2: 9–16
Gader AMA, da Costa J, Cash JD (1974) The effect of propanolol, and practolol on the fibrinolytic and factor VIII responses to adrenaline and salbutamol in man. Thromb Res 4: 25–33
Gallimore MJ (1984) Das Plasma-Kallikrein-Kinin-System und Antithrombin III. In: Köstering H (Hrsg) Antithrombin III. Schattauer, Stuttgart, S 17–26
Gallimore MJ (1985) Chromogenic peptide substrate assays for determining components of the plasma kallikrein system. Scand J Clin Lab Invest [Suppl 178] 45: 127–132
Gallimore MJ, Friberger P (1982) Simple chromogenic substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein,like‘ activity in human plasma. Thromb Res 25: 293–298
Gallimore MJ, Aasen AO, Smith-Erichsen N, Larsbraaten M, Lyngaas K, Amundsen E (1980) Plasminogen concentrations and functional activities and concentrations of plasmin inhibitors in plasma samples from normal subjects and patients with septic shock. Thromb Res 18: 601–608
Gavras H, Oliver N, Aitchison J et al. (1975) Abnormalities of coagulation and the development of malignant phase hypertension. Kidney Int 8: 252–261
George CRP, Slichter SJ, Quadracci U, Striker GE, Harker LA (1974) A kinetic evaluation of hemostasis in renal disease. N Engl J Med 291: 1111–1115
George CRP, Slichter SJ, Quadracci LJ, Kenny GM, Dennis MB, Striker GE, Harker LA (1975) The treatment of rejection. A trial of acetylsalicylic acid, dipyridamole, and heparin. Transplantation 20: 237–240
Gilboa N, Erdman J, Urizar RE (1982) Quantitative spectrophotometric assay of renal tissue plasminogen activator. Kidney Int 22: 80–83
Girndt J, Scheler F, Bohle A (1978) Blutgerinnungsstörungen, ein pathogenetischer Faktor für Nephrosklerose und Hochdruck. Dtsch Med Wochenschr 5: 199–204
Giroux L, Boury F, Smeesters C, Corman J, Daloze PM (1981) Modifications of glomerular fibrinolysis in human renal graft rejection. J Surg Res 31: 253–258
Godal HC, Abildgaard U, Kierulf P (1971) Ethanol gelation and fibrin monomers in plasma. Scand J Haematol 13: 189–191
Goldstein MH (1979) Hemolytic-uremic syndrome. Nephron 23: 263–272
Gralnick HR, Marchesi S, Givelber H (1972) Intravascular coagulation in acute leukemia: clinical and subclinical abnormalities. Blood 40: 709–718
Griffin JH, Cochrane CG (1979) Recent advances in the understanding of contact activation reactions. Semin Thromb Hemost 5: 254–273
Griffin PJA, Salaman JR (1981) A controlled trial of heparin in renal transplant rejection. Transplantation 32: 306–307
Grino JM, Alsina J, Martin J, Roca M, Castelao A, Romero R, Caralps A (1982) Indium-Ill labeled autologous platelets as a diagnostic method in kidney allograft rejection. Transplant Proc 14: 198–200
Grünfeld JP, Ganeval D, Bournerias F (1980) Acute renal failure in pregnancy. Kidney Int 18: 179–191
Gunnarsson B, Asaba H, Dawidson S, Wilhelmsson S, Bergström J (1981) The effects of three different heparin regimes on heparin concentration in plasma and fibrin formation in dialyzers. Clin Nephrol 15: 135–142
Gurewich V, Lipinski B (1976) Semiquantitative determination of soluble fibrin monomer complexes by chromatography and serial-dilution protamine sulfate test. Am J Clin Pathol 65: 397–401
Haas G (1926) Über Versuche der Blutauswaschung am Lebenden mit Hilfe der Dialyse. Naunyn Schmiedebergs Arch Pharmacol 116: 158–172
Haas G (1927) Versuche mit Blutauswaschung am Lebenden mit der Hilfe der Dialyse. Naunyn Schmiedebergs Arch Pharmacol 120: 371–386
Haberland GL (1978) The role of kininogenases, kinin formation and kininogenase inhibition in post traumatic shock and related conditions. Klin Wochenschr 56: 325–331
Hakim RM, Schafer AI (1985) Hemodialysis-associated platelet activation and thrombocytopenia. Am J Med 78: 575–580
Hakim RM, Fearon DT, Lazarus JM (1984) Biocompatibility of dialysis membranes: effects of chronic complement activation. Kidney Int 26: 94–100
Hall CL, Nooshabeh P, Thomson RW et al.(1973) Serial estimation of urinary fibrin/fibrinogen degradation products in kidney transplantation. Br Med J 3: 204–207
Halloran PF, Aprile M, Haddad G, Robinette M (1982) The significance of elevated procoagulant activity in the monocytes of renal transplant recipients. Transplant Proc 14: 669–672
Halloran PF, Aprile MA, Haddad GJ, Robinette MA (1985) Procoagulant activity in renal transplant recipients. Transplantation 39: 374–377
Hamsten A, Wiman B, De Faire U, Blombäck M (1985) Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 313: 1557
Harter R, Burch JW, Majerus PW, Stanford N, Delmez JA, Anderson CB, Weerts CA (1979) Prevention of thrombosis in patients on hemodialysis by low-dose aspirin. N Engl J Med 301: 577–579
Hattler BG, Rocklin RE, Ward PA, Rickles FR (1973) Functional features of lymphocytes recovered from a human allograft. Cell Immunol 9: 289–295
Haupt H, Bachmann HJ, Tache E (1974) Urokinaseausscheidung bei Verbrauchskoagulopathie und akutem Nierenversagen. Monatsschr Kinderheilkd 122: 622–623
Hawkey CM, Britton BJ, Wood WG, Peele M, Irving MH (1975) Changes in blood catecholamine levels and blood coagulation and fibrinolytic activity in response to graded exercise in man. Br J Haematol 29: 377–384
Hayasaka T, Yoshiki T, Shiral T, Ninomura N, Ithoh T (1981) Comparative immunopathologic studies of thrombotic thrombocytopenic purpura, hemolytic-uremic syndrome and disseminated intravascular coagulation. Acta Pathol Jpn 31: 569–581
Hayslett JP (1985) Postpartum renal failure. N Engl J Med 312: 1556–1559
Hedner U, Nilsson IM (1971) Urokinase inhibitors in serum in a clinical series. Acta Med Scand 189: 185–189
Hedner U, Nilsson IM (1971) Clinical experience with determination fibrinogen degradation products. Acta Med Scand 189: 471–477
Hedner U, Nilsson IM (1973) Pattern of the activator inhibitor in carcinoma and renal diseases. Scand J Haematol 11: 398–404
Heene DL (1977) Disseminated intravascular coagulation. Evaluation of therapeutic approaches. Semin Thromb Hemost 3: 291–317
Heene DL, Matthias FR (1978) Hämostasestörungen im Schock. Verh Dtsch Ges Pathol 62: 103–111
Heene DL, Kirschstein W, Dempfle CE (1984) Shock-induced alterations in hemostasis. Klin Wochenschr [Suppl VII] 64: 14–17
Heimark RL, Kurachi K, Fugikawa K, Dawie EW (1980) Surface activation of blood coagulation, fibrinolysis and kinin formation. Nature 286: 456–460
Heimburger N (1980) Antithrombin III/Biochemische Wirkung. In: Marx R, Thies HA (Hrsg) Kontrolle von Antithrombotika. Roche, Grenzach, S 79–84
Hellgren M, Hägnerik K, Robbe H, Björk O, Blombäck M, Eklund J (1983) Severe acquired antithrombin III deficiency in relation to hepatic and renal insufficiency and intrauterine fetal death in late pregnancy. Gynecol Obstet Invest 16: 107–118
Hellgren M, Javelin L, Hägnevik K, Blombäck M, Meden-Britth G (1984) Antithrombin III concentrate as adjuvant in DIC treatment - a pilot study in 9 severely ill patients. Thromb Res 35: 459–466
Hickman JA (1971) A study of the metabolism of fibrinogen after surgical operations. Clin Sei 41: 141–152
Hiepert LM, Jacques CB (1976) Heparin uptake on endothelium. Artery 2: 26–37
Highsmith RF, Kline DL (1971) Kidney: primary source of plasminogen after acute depletion in the cat. Science 174:141–142
Highsmith RF, Kline DL (1973) Plasminogen restoration by the kidney mediated by a plasma factor. Am J Physiol 225: 1032–1037
Hildebrand U, Quellhorst E (1985) Influence of various membranes on the coagulation system during dialysis. Contrib Nephrol 46: 92–101
Hiller E, Saal JG, Ostendorf P, Griffiths JW (1977) The procoagulant activity of human granulocytes, lymphocytes and monocytes stimulated by endotoxin. Klin Wochenschr 55: 751–757
Hirsh J (1981) Blood tests for the diagnosis of venous and arterial thrombosis. Blood 57: 1–8
Hirsh J (1984) Heparin induced bleeding. Nouv Rev Fr Hematol 266: 261–266
Hogg N (1983) Human monocytes have prothrombin cleaving activity. Clin Exp Immunol 53: 725–739
Hoie J (1975) Renal vascular resistance changes following thrombin-induced intravascular coagulation: role of platelet and fibrin emboli. Acta Chir Scand 141: 167–172
Hoie J, Schenk WG (1972) Experimental intravascular coagulation: impairment of renal blood flow following thrombin infusion in the dog. J Trauma 12: 302–308
Holmer E, Lindahl U, Bäckström G, Thunberg L, Sandberg H, Söderström G, Andersson L-O (1980) Anticoagulant activities and effect on platelets of a heparin fragment with high affinity for antithrombin. Thromb Res 18: 861–869
Holmer E, Mattson C, Nilsson S (1982) Anticoagulant and antithrombotic effects of heparin and low molecular weight heparin fragments in rabbits. Thromb Res 25:475–485
Hopper KE, Geczy CL, Davies WA (1981) A mechanism of migration inhibition in delayed-type hypersensitivity reactions. I. Fibrin deposition on the surface of elicited peritoneal macrophages in vivo. J Immunol 126: 1052–1058
Hörl WH, Schäfer RM, Heidland A (1985) Effect of different dialysers on proteinases and proteinase inhibition during hemodialysis. Am J Nephrol 8: 320–326
Hörl WH, Steinhauer HB, Schollmeyer P (1985) Plasma levels of granulocyte elastase during hemodialysis: effects of different dialyzer membranes. Kidney Int 28: 791–796
Hoyer JR, Michael AF, Hoyer LW (1974) Immunofluorescent localization of antihemophilic factor antigen and fibrinogen in human renal diseases. J Clin Invest 53:1375–1384
Hoyer LW (1981) The factor VIII complex: structure and function. Blood 58: 1–13
Hulme B, Pitcher PM (1973) Rapid latex-screening test for detection of fibrin/fibrinogen degradation products in urine after renal transplantation. Lancet I: 6–8
Huser B, Lämmle B, Tran TH, Oberholzer M, Thiel G, Duckert F (1984) Hämostase-Kriterien bei Nierentransplantatträgern. Schweiz Med Wochenschr 114: 1149–1154
Huttunen JK, Pasternack A, Vänttinen T, Ehnholm C, Nikkilä EA (1978) Lipoprotein metabolism in patients with chronic uremia. Acta Med Scand 204: 211–218
Ibels LS, Reardon MF, Nestel PJ (1976) Plasma post-heparin lipolytic activity and triglyceride clearance in uremic and hemodialysis patients and renal allograft recipients. J Lab Clin Med 87: 648–658
Ingram GIC, Jones RV (1966) The rise in clotting factor VIII induced in man by adrenaline: effect of alpha- and beta-blockers. J Physiol 187: 447–454
Ingram GIC, Jones RV, Hershgold EJ, Denson KWE, Perkins JR (1977) Factor VHI-activity and antigen, platelet count and biochemical changes after adrenoceptor stimulation. Br J Haematol 35: 81–99
Ireland H, Lane DA, Curtis JR (1984) Objective assessment of heparin requirements for hemodialysis in humans. J Lab Clin Med 103: 643–652
Isacson S, Nilsson IM (1969) The kidneys and the fibrinolytic activity in the blood. Thromb Diath Haemorrh 22: 211–215
Isacson S, Nilsson IM (1972) Defective fibrinolysis in blood and vein walls in recurrent idiopathic venous thrombosis. Acta Chir Scand 138: 313–319
Isles C, Lowe GDO, Rankin BM, Forbes CD, Lucie N, Lever AF, Kennedy AC (1984) Abnormal haemostasis and blood viscosity in malignant hypertension. Thromb Haemost 52: 253–255
Ito S, Camussi G, Telta C, Milgrom F, Andres G (1984) Hyperacute renal allograft rejection in the rabbit. Lab Invest 51: 148–161
Ito T, Niva T, Matsai E (1972) Fibrinolytic activity in renal disease. Clin Chim Acta 36: 145–151
Ivanovich P, Chenoweth DE, Schmidt R, Klinkmann H, Boxer LA, Jacob HS, Hammerschmidt DE (1983) Symptoms and activation of granulocytes and complement with two dialysis membranes. Kidney Int 22: 758–763
Jaffe EA (1977) Endothelial cells and the biology of factor VIII. N Engl J Med 296: 377–383
Janson PA, Jubelirer SJ, Weinstein MJ, Deykin D (1980) Treatment of the bleeding tendency in uremia with cryoprecipitate. N Engl J Med 303: 1318–1322
Januszko T, Furman M, Buluk K (1966) The kidneys and the liver as the organs regulating the fibrinolytic system of the circulating blood. Thromb Diath Haemorrh 15: 554–560
Jones FE, Black PJ, Cameron JS et al. (1975) Local infusion of urokinase and heparin into renal arteries in independing renal cortical necrosis. Br Med J 4: 547–549
Jörgensen M, Eriksen HO, Tranebjoerg L (1985) Plasma antithrombin III concentration in patients on regular haemodialysis treatment. Nephron 40: 22–24
Jubelirer SJ (1985) Hemostatic abnormalities in renal disease. Am J Kidney Dis 5: 219–225
Jurewicz WA, Dykes JGA, Gunson BK, Chandler ST, Hawker RJ, Barnes AD (1984) Indium-Ill-labeled platelets as a diagnostic aid in posttransplant monitoring of renal allografts in humans. Transplant Proc 16: 1481–1483
Kadish JL (1979) Fibrin and atherogenesis- a hypothesis. Atherosclerosis 33: 409–413
Kane K (1984) Fibrinolysis - a review. Ann Clin Lab Sei 14: 443–449
Kanfer A (1982) Coagulation and renal diseases. Proc Eur Dial Transplant Assoc Eur Ren Assoc 19: 703–713
Kanfer A, Vandewalle A, Beaufils M, Delarue F, Sraer JD (1975) Enhanced antiplasmin activity in acute renal failure. Br Med J 4: 195–197
Kaplan AP (1978) Initiation of the intrinsic coagulation and fibrinolytic pathways of man: the role of surfaces, Hageman factor, prekallikrein, high molecular weight kininogen and factor XI. Prog Heamost Tromb 4: 127–175
Kaplan AP, Yecies LD (1980) Initiation of Hageman-factor-dependent fibrinolysis. In: Kline DL, Reddy KNN (eds) Fibrinolysis. CRC Press, Boca Raton, pp 43–69
Kaplan JE (1979) Effect of reticuloendothelial blockade on the development of hypertension after trauma, sepsis, and intravascular coagulation. Adv Shock Res 2: 73–81
Kaplinsky C, Frand M, Rubinstein ZJ (1980) Disseminated intravascular clotting and renal cortical necrosis complicating a snake bite. Clin Pediatr 19: 229–231
Karges HE, Heimburger N (1984) Grundlagen und Biochemie des Antithrombin III. In: Köstering H (Hrsg) Antithrombin III. Schattauer, Stuttgart, S 7–16
Kauffman HM, Ekbom GA, Adams MB, Hussey CV (1979) Hypercoagulability: a cause of vascular access failure. Proc Clin Dial Transplant Forum 9: 28–31
Keber D, Stegnar M, Keber I, Accetto B (1979) Influence of moderate and strenuous daily physical activity on fibrinolytic activity of blood: possibility of plasminogen activator stores depletion. Thromb Haemost 41: 745–755
Kierulf P, Aasen AO, Aune S, Godal HC, Ruud TE, Vaage J (1982) Chromogenic peptide substrate assays in patients with multiple trauma. Acta Chir Scand [Suppl] 509: 69–72
Kincaid-Smith P (1969) Modification of the vascular lesions of rejection in cadaveric renal allografts by dipyridamole and anti-coagulants. Lancet II: 920–922
Kincaid-Smith P (1970) The pathogenesis of the vascular and glomerular lessions of rejection in renal allografts and their modification by anti-thrombotic and anticoagulant drugs. Aust Ann Med 19: 201–214
Kincaid-Smith P (1972) Coagulation and renal disease. Kidney Int 2: 183–190
Kincaid-Smith P (1973) The role of coagulation in the obliteration of glomerular capillars. Perspect Nephrol Hypertens 2: 871–890
Kincaid-Smith P (1975) Participation of intravascular coagulation in the pathogenesis of glomerular and vascular lesions. Kidney Int 7: 242–253
King DJ, Kelton JG (1984) Heparin-associated thrombocytopenia. Ann Intern Med 100: 535–540
Kirchstein W, Heene DL (1985) Fibrinolysis inhibition in acute respiratory distress syndrome. Scand J Clin Lab Invest [Suppl 178] 45: 87–94
Kitamura T, Oshi M, Umeda T, Ueno A, Nijima T (1984) Postoperative acute renal and hepatic failure in a case of pheochromocytoma, possibly induced by disseminated intravascular coagulation. Jpn J Nephrol 26: 309–317
Kleinknecht D, Verger D, Mignon F, Richet G (1970) Insuffisance renale et pancreatite aigue. Signification des depots fibrinoides intraglomerulaires. Ann Med Interne (Paris) 121: 17–28
Kleinknecht D, Jungers P, Clianard J et al. (1972) Uremic and non-uremic complications in acute renal failure. Evaluation of early and frequent dialysis on prognosis. Kidney Int 1: 190–196
Kleinknecht D, Kanfer A, Josso F (1972) Intravascular coagulation and heparin therapy in acute renal failure: a reappraisal. Rev Eur Etud Clin Biol 17: 695–700
Kleinknecht D, Grünfeld JP, Gomez PC, Moreau JF, Garcia-Torres R (1973) Diagnostic procedures and long-term prognosis in bilateral renal cortical necrosis. Kidney Int 4: 390–400
Kluft C, Wijngaards G, Jie AFH (1981) The factor XII-independant plasminogen proactivator system of plasma includes urokinase-related activity. Thromb Haemost 46: 343
Kluft C, Wijngaards G, Jie AFH (1983) Intrinsic plasma fibrinolysis: involvement of urokinase related activity in the factor XII-independent plasminogen proactivator pathway. In: Davidson JF, Bachmann F, Bouvier CA, Kruithof EKO (eds) Progess in fibrinolysis VI. Churchill Livingstone, Edinburgh London New York, pp 43–45
Kluft C, Wijngaards G, Jie AFH (1984) Intrinsic plasma fibrinolysis: involvement of UK-related activity in the factor XII-independent plasminogen proactivator pathway. J Lab Clin Med 103: 405–419
Knudsen F, Dyerberg J (1985) Platelets and antithrombin III in uraemia: the acute effect of haemodialysis. Scand J Clin Lab Invest 45: 341–347
Koffler D, Paronetto F (1966) Fibrinogen deposition in acute renal failure. Am J Pathol 49: 383–395
Kopitsky RG, Switzer MEP, Sanders Williams R, McKee PA (1983) The basis for the increase in factor VIII procoagulant activity during exercise. Thromb Haemost 49: 53–57
Köstering H (1974) Blutungskomplikationen bei Patienten mit terminaler Niereninsuffizienz. Aktuel Nephrol 3: 99–110
Köstering H (1981) Die Thromboembolien. Schattauer, Stuttgart
Köstering H (1984) Antithrombin III. Schattauer, Stuttgart
Köstering H, Kreuzer H, Neuhaus KL (1986) Thrombolytische Therapie des akuten Myokardinfarktes. Schattauer, Stuttgart
Kramer P (1985) Arteriovenous hemofiltration. Springer, Berlin Heidelberg New York Tokyo
Krug H, Raszeja-Wanic B, Wochowiak A (1974) Intravascular coagulation in acute renal failure after myocardial infarction. Ann Intern Med 81: 494–497
Kucinsky CS, Fletcher AP, Sherry S (1968) Effect of urokinase antiserum on plasminogen activators: demonstration of immunologic dissimilarity between plasma plasminogen activator and urokinase. J Clin Invest 47: 1238–1253
Kuhlbäck B (1957) Bleeding tendency in chronic renal failure. Acta Med Scand 157: 173–177
Kwaan HC (1979) Physiologic and pharmacologic implications of fibrinolysis. Artery 5: 285–290
Kwaan HC (1984) The role of fibrinolysis in disease processes. Semin Thromb Hemost 10: 71–79
Kwaan HC, Anderson MC, Gramatica L (1971) A study of pancreatic enzymes as a factor in the pathogenesis of disseminated intravascular coagulation during acute pancreatitis. Surgery 69: 663–672
Lämmle E, Tran TH, Ritz R, Duchert F (1984) Plasma prekallikrein, factor XII, antithrombin III, C 1-inhibitor and alpha2-macroglobulin in critically ill patients with suspected disseminated intravascular coagulation (DIC). Am J Pathol 82: 396–404
Larsson LI, Skeriver L, Nielsen LS, Grondall-Hansen J, Kristensen P, Dano K (1984) Distribution of urokinase-type plasminogen activator immunoreactivity in the mouse. J Cell Biol 98: 894–903
Larsson SO (1971) On coagulation and fibrinolysis in uraemic patients on maintenance haemodialysis. Acta Med Scand 189: 453–462
Larsson SO, Hedner U, Nilsson IM (1971) On coagulation and fibrinolysis in acute renal insufficiency. Acta Med Scand 189: 443–451
Lasch HG (1975) Verbrauchskoagulopathie-Ursache und Folge von Blutungen. Med Welt 26: 697–703
Lasch HG, Schütterle G (1970) Niere und Hämostase. Klin Wochenschr 48: 1019–1024
Lazarus JM (1980) Complications in hemodialysis: an overview. Kidney Int 18: 783–796
Lee L, House PH, Cohen MH (1966) The role of the reticuloendothelial system in diffuse low grade intravascular coagulation. In: Brinkhouse K, Wright JS, Koller F, Strauli E, Duckert F (eds) Diffuse intravascular clotting. Schattauer, Stuttgart, pp 87–95
Leithner S, Sinzinger H, Schwarz M (1981) Treatment of chronic kidney transplant rejection with prostacyclin - reduction of platelet deposition in the transplant: prolongation of platelet survival and improvement of transplant function. Prostaglandins 22: 783–788
Leithner S, Sinzinger H, Pohanka I, Schwarz M, Kretschmer G, Syre G (1983) Occurrence of haemolytic uraemic syndrome under cyclosporine treatment: accident or possible side effect mediated by a lack of prostacyclin-stimulating plasma factor. Transplant Proc 15: 2787–2789
Lewis JH, Zucker MB, Ferguson JH (1956) Bleeding tendency in uremia. Blood 11: 1073–1076
Lian ECY, Nunez RL, Harkness DR (1976) In vivo and in vitro effects of thrombin and plasmin on human factor VIII (AHF). Am J Hematol 1: 481–491
Liehr H (1982) Die Bedeutung der Leber und des RES im Schock. Hämostaseologie 2: 68–72
Lijnen HR, Collen D, Verstraete M (1980) Synthetic substrates in clinical blood coagulation assays. Nijhoff, The Hague Boston London
Lindner A, Charra D, Sherrard DF, Scribner BH (1974) Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290: 697–701
Lindquist RR, Guttmann RD, Merrill JP, Dammin GJ (1968) Human renal allografts: interpretation of morphologic and immunohistochemical observations. Am J Pathol 5: 851–881
Lindsay RM, Moorthey AV, Koens F, Linton AL (1975) Platelet function in dialyzed and non dialyzed patients with chronic renal failure. Clin Nephrol 4: 52–57
Lindsay RM, Friesen M, Koens F, Linton AL, Oreopoulos D, De Yeber G (1976) Platelet function in patients on long term peritoneal dialysis. Clin Nephrol 6: 335–339
Lipinski B, Worowski K (1968) Detection of soluble fibrin monomer complexes by means of protamine-sulfate-test. Thromb Diath Haemorrh 20: 44–49
Llach F (1985) Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome. Kidney Int 28: 429–439
Losman JG, Rose AG, Barnard CN (1977) Myocardial fibrinolytic activity in allogenic cardiac rejection. Transplantation 23: 414–422
Losonczy G (1984) Intrarenal blood coagulation induced by ischemia in rats. Heparin and thrombozytopenia does not prevent the intracortical fibrin formation. Thromb Res 34: 87–92
Losonczy G, Harsing L (1982) Simultaneous activation of coagulation and fibrinolysis after severe renal ischemia in rats. Nephron 32: 180–184
Losowsky MS, Walls WD (1971) Abnormalities of haemostasis in renal failure. J R Coll Physicians Lond 5: 148–156
Lowenhaupt R, Nathan P (1968) Platelet accumulation observed by electron microscopy in the early phase of renal allotransplant rejection. Nature 220: 822–825
Lüscher EF (1982) The role of blood cells and of the vessel wall in the induction of intravascular coagulation. Klin Wochenschr 60: 710–712
Lyberg T (1984) Clinical significance of increased thromboplastin activity on the monocyte surface-a brief review. Haemostasis 14: 430–439
MacDonald AS, Busch GJ, Alexander JL, Pheteplace EA, Menzoian J, Murray JE (1970) Heparin and aspirin in the treatment of renal allografts in presensitized dogs. Transplantation 9:1–7
MacDonald AS, Bell WR, Busch GJ, Ghose T, Chan CC, Falvey CF, Merrill JP (1972) A comparison of hyperacute canine renal allograft and sheep-to-dog xenograft rejection. Transplantation 13: 146–154
MacDonald MK, Clarkson AR, Davison AM (1973) The role of coagulation in renal disease. Perspect Nephrol Hyptertens 2: 809–828
MacFarlane RG, Pilling J (1947) Fibrinolytic activity of normal urine. Nature 159: 779
Maher JF, Lapierre L, Schreiner GE, Geiger M, Westervelt FB (1968) Regional heparinization for hemodialysis. N Engl J Med 268: 451–456
Mandalaki T, Dessypris A, Louizon C, Bossinakou I, Panayotopoulou C, Antonopoulou A (1977) Marathon run: effects on blood coagulation an fibrinolysis. Thromb Haemost 37: 444–450
Mandel SR, Shermer R, Clark R, Staab EV, Webster WP (1979) Thrombosis: a study of coagulation parameters and mechanisms during allograft rejection. Thromb Haemost 41: 553–566
Mann LT, Jensenius JC, Simonsen M, Abildgaard U (1969) Antithrombin III: protection against death after injection of thromboplastin. Science 166: 517–518
Mannhalter C, Deutsch E, Kopsa H (1985) Clotting activities and antigen concentrations of contact factors in kidney disease. Thromb Res 39: 475–484
Mannucci PM, Remuzzi G, Pusineri F, Lombardi R, Valsecchi C, Mecca G, Zimmerman TS (1983) Deamino-8-d-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med 308: 8–12
Mansfield AD (1972) Alteration in fibrinolysis associated with surgery and venous thrombosis. Br J Surg 59: 754–757
Mant MJ, Garner King E (1979) Severe, acute disseminated intravascular coagulation: a reappraisal of its pathophysiology, clinical significance and therapy based on 47 patients. Am J Med 67: 557–563
Marciniak E, Gockerman JP (1977) Heparin induced clearance in circulating antithrombin III. Lancet II: 581–584
Markiewicz A (1971) Urokinase activity in acute renal failure. Pol Med J 10: 837–843
Mason RG, Chuang HYK, Fazal Mohammad S, Sharp DH (1978) Extracorporeal thrombogenesis and anticoagulation. Nijhoff, The Hague Boston London, pp 199–216
Mathew TH, Clyne DH, Nanra RS, Kincaid-Smith P, Saker BM, Morris PJ, Marshall VC (1974) A controlled trial of oral anticoagulants and dipyridamole in cadaveric renal allografts. Lancet I: 1307–1310
Matlin RA, Gary NE (1974) Acute cortical necrosis, case report and review of the literature. Am J Med 56: 110–118
Matthew TH, Lewers DT, Hogan GP et al. (1971) The induction of vascular renal allograft rejection by leucocyte sensitization. J Lab Clin Med 77: 396–409
Matthias FR, Lasch HG (1982) Disseminierte intravaskuläre Gerinnung und Kreislaufschock. Haemostaseologie 2: 60–67
McConnel D, Johnson JG, Young L, Holemans R (1966) Localization of plasminogen activator in kidney tissue. Lab Invest 15: 980–986
McKay DG (1969) Tissue damage in disseminated intravascular coagulation - mechanisms of localization of thrombi in the microcirculation. Thromb Diath Haemorrh [Suppl] 36: 67–81
McKay DG (1973) Blood coagulation and renal disease. Perspect Nephrol Hypertens 2: 771–828
McMillan R (1968) Heparin in delayed transplant function. Lancet I:1178–1180
McMurray SD, Luft FC, Maxwell DR et al.(1978) Prevailing patterns and predictor variables in patients with acute tubular necrosis. Arch Intern Med 138: 950–955
McNicol GP, Barakat AA, Douglas AS (1965) Plasma fibrinolytic activity in renal disease. Scott Med J 10: 189–194
Meade TW, Chakrabarti R, Haines AP, Stirling Y (1979) Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. Br Med J 1:153–156
Meade TW, Chakrabarti R, Haines AP, North WRS, Stirling Y, Thompson SG (1980) Haemostatic function and cardiovascular death: early results of a prospective study. Lancet II: 1050–1053
Melissari E, Scully MF, Paes T, Kakkar VV (1985) The influence of LMW heparin on the coagulation and fibrinolytic response to surgery. Thromb Res 37:115–126
Menon IS, Dewar HA, Newell DJ (1968) Role of the kidney in fibrinolytic activity of the blood. Lancet I: 785–788
Mettinger KL (1982) A study of hemostasis in ischemic cerebrovascular disease. V. A multivariate evaluation of risk indicators and predictors. Early results of a longitudinal study. Thromb Res 28: 521–532
Mettinger KL, Egberg N (1982) A study of hemostasis in ischemic cerebrovascular disease. III. Abnormalities in vascular plasminogen activators, antiactivators and alpha-2 antiplasmin. Thromb Res 26: 203–210
Miles AL, Rothschild Z, Griffin JH (1981) Dextran sulfate stimulated fibrinolytic activity in whole human plasma: dependence on the contact activation system and on a urokinase related antigen. Thromb Haemost 46: 211
Moberg AW, Shons AR, Gewürz H, Mozes M, Najarian JS (1971) Prolongation of renal xenografts by the simultaneous sequestration of performed antibody, inhibition of complement, coagulation and antibody synthesis. Transplant Proc 3: 538–541
Monserrat AJ, Murso AM, Tartas et al. (1981) Consumption coagulopathy in acute renal failure induced by hypolipotropic diets. Nephron 28: 276–284
Mottin D, Rondeau E, Delarue F, Bens M, Doleris LM, Sraer JD (1984) Arachidonic acid metabolites of isolated glomeruli after thrombin induced intravascular coagulation: Role of cyclooxygenase and lipoxygenase metabolites. Eur J Clin Invest [Suppl] 14: 60
Müller-Berghaus G, Röka L, Lasch HG (1973) Induction of glomerular microdot formation by fibrin monomer infusion. Thromb Diath Haemorrh 29: 375–383
Müller-Berghaus G, Bohn E, Höbel W (1976) Activation of intravascular coagulation by endotoxin: the significance of granulocyte and platelets. Br J Haematol 33: 213–220
Muntean W, Goriup U (1975) Disseminierte intravasale Gerinnung und akutes Nierenversagen bei einem Säugling. Wien Klin Wochenschr 7: 792–796
Myburgh JA, Cohen I, Gecelter L et al. (1969) Hyperacute rejection in human-kidney allografts-shwartzman or arthus reaction? N Engl J Med 281: 131–135
Myhre-Jensen O (1971) Localisation of fibrinolytic activity in the kidney and urinary tract of rats and rabbits. Lab Invest 25: 403–411
Myhre-Jensen O, Lund B (1972) Fibrinolytic activity of renal transplants in rabbits relation to graft thrombosis and necrosis. Acta Pathol Microbiol Scand 80: 651–658
Myhre-Jensen O, Hansen ES, Buitrago B (1972) Renal microthrombosis. Acta Pathol Microbiol Scand 80: 403–411
Nakamura M, Takahashi K, Naora H, Tsunematsu T (1984) A monoclonal antibody against human urokinase: characterization of the epitope and its localization in human kidney. Cell Struct Funct 9: 167–179
Neild GH, Ivory K, Williams DG (1983) Glomerular thrombi and infarction in rabbits with serum sickness following cyclosporine therapy. Transplant Proc 15: 2782–2786
Neild GH, Rocchi G, Imberti L, Fumagalli F, Brown Z, Remuzzi G, Williams DG (1983) Effect of cyclosporin A on prostacyclin synthesis by vascular tissue. Thromb Res 32: 373–379
Neild GH, Reuben R, Hartley RB, Cameron JS (1985) Glomerular thrombi in renal allografts associated with cyclosporin treatment. J Clin Pathol 38: 253–258
Nelson PH, Moser KM, Stoner C, Moser KS (1982) Risk of complication during intravenous heparin therapy. West J Med 136: 189–197
Nemerson Y (1983) Regulation of the initiation of coagulation by factor VII. Haemostasis 13: 150–155
Nenci GG, Berrettini M, Agnelli G, Parise P, Buoncristiani U, Ballatori E (1979) Effect of peritoneal dialysis haemodialysis and kidney transplantation on blood platelet function. Nephron 23: 287–292
Niewiarowski S (1981) Platelet release reaction and secretal platelet proteins. In: Bloom AL, Thomas DP (eds) Haemostasis and thrombosis. Churchill Livingstone, Edinburgh London New York, pp 73–83
Niewiarowski S, Prokopowicz J, Poplawski A, Worowski K (1964) Inhibition of dog fibrinolytic system in experimental tubular necrosis of kidney. Experientia 20: 101–103
Nilsen DWT, Jeremic M, Weisert OK (1980) An attempt at predicting post-operative deep vein thrombosis by preoperative coagulation studies in patients undergoing total hip replacement. Thromb Haemost 43: 194–197
Nishimoto K, Yamagami S, Katoh Y, Kishimoto T, Maekawa M, Okada K, Matsuo O (1986) Coagulation and fibrinolysis in chronic renal failure. Change in tissue-type plasminogen activator activity. ASAIO Trans 32: 478–481
Nordoy A, Visk-Mo H, Mjös OD, Johnson R (1977) Free fatty acids in plasma and platelets following low and high-dose heparin during alimentary hyperlipaemia. Acta Med Scand 202: 163–171
Nossel HL (1976) Radioimmunoassay of fibrinopeptides in relation to intravascular coagulation and thrombosis. N Engl J Med 295: 428–432
Notohamiprodjo M, Andrassy K, Bommer J, Ritz E (1986) Dialysis membranes and coagulation systems. Blood Purif 4: 130–141
Oehler G, Matthias FR, Lasch HG (1986) Gerinnungsveränderungen im Schock. Behring Inst Mitt 7: 142–153
Olson JL (1984) Role of heparin as a protective agent following reduction of renal mass. Kidney Int 25: 376–382
Ono I, Ohura T, Azami K, Hoshi M, Hasegawa T (1984) Anticoagulation therapy for renal insufficiency after burns. Burns 11: 104–110
Ostendorf P, Jaschonek K, Daiß W (1985) Disseminierte intravasale Gerinnung (DIC) und Verbrauchskoagulopathie. Hämostaseologie 5: 44–53
Österud B, Björklid E (1982) The production and availability of tissue thromboplastin in cellular populations of whole blood exposed to various concentrations of endotoxin. Scand J Haematol 29: 175–184
Panicucci F, Sagripanti A, Pinori E, Vispi M, Lecchini L, Barsotti G, Giovannetti S (1983) Comprehensive study of haemostasis in chronic uraemia. Nephron 33: 5–8
Partecke BD, Fischer C, Buck-Gramcko D (1985) Antithrombin III - ein wichtiger Faktor bei langdauernden mikrovaskulären Operationen. Handchirurgie 17: 81–85
Paye Y, Lehot JJ, Rousselet B (1983) High-bleeding risk in acute renal failure: hemodialysis with dipyridamole as the sole antithrombotic agent. Agressologie 24: 601–603
Persson E, Nordenström J, Nilsson-Ehle P, Hagenfeldt L (1985) Lipolytic and anticoagulant activities of a low molecular weight fragment of heparin. Eur J Clin Invest 15: 215–220
Pinaick RV, Wiegmann TB, Diederich DA (1983) Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding. N Engl J Med 308: 258–261
Pineo GF, Regoeczi E, Dempster WJ (1970) The nature of experimental second-set kidney transplant rejection. 1. The role of coagulation in hyperacute (second-set) renal allotransplant rejection in dogs. Br J Exp Pathol 51: 547–562
Pixley RA, Schapira M, Colman RW (1985) The regulation of human factor XII a by proteinase inhibitors. J Biol Chem 260: 1723–1729
Ponticelli C, Ruggeri ZM, Gordon YB et al.(1979) Urinary excretion of factor-VIII-related antigen and fibrin(ogen) degradation fragments D and E after kidney transplantation. Transplant Proc 11: 448–451
Porter KA (1967) Rejection in treated renal allografts. J Clin Pathol [Suppl] 20: 518–534
Preston FE, Ward AM (1972) Acute renal failure in myelomatosis from intravascular coagulation. Br Med J I: 604–605
Previato G, Loschiavo C, Lupo A et al. (1981) Clinical significance of plasma factor VIII levels in renal disease. Clin Nephrol 16: 200–206
Prowse CV, Cash JD (1984) Physiologic and pharmacologic enhancement of fibrinolysis. Semin Thromb Hemost 10: 51–60
Prydz H, Lyberg T (1980) Tissue thromboplastin - molecular and cellular biology. Protides Biol Fluids 28: 241–244
Pultavituma A, Azcarate J, Mammen EF, Rosenberg B, Rosenberg JC (1972) Coagulation and platelet changes in rejected renal allografts. Arch Surg 105: 255–259
Purkerson ML, Joist JH, Greenberg JM, Kay D, Hoffsten PE, Klahr S (1982) Inhibition by anticoagulant drugs of the progressive hypertension and uremia associated with renal infarction in rats. Thromb Res 26: 227–240
Rabiner SF (1972) Uremic bleeding. Prog Hemost Thromb 1: 233–250
Rabiner SF (1972) Bleeding in uremia. Med Clin North Am 56: 221–233
Radegran K, Cronestrand R, Olsson P (1970) The effect of regional thrombin infusion on the renal vascular resistance. Eur Surg Res 2: 460–472
Rammer L (1973) Renal function after intravascular coagulation in the rat kidney. Urol Res 1: 166–169
Rammer L, Gerdin B (1975) Protection against the impairment of renal function after intravascular coagulation in the rat kidney by increased ingestion of sodium chloride. Nephron 14: 433–441
Rammer L, Stahl E (1979) Effect of beta-adrenergic blockade by propanolol upon intravascular coagulation in the rat kidney. Nephron 24: 246–249
Rao KV, Smith EJ, Alexander JW, Fidler JP, Pemmaraju SR, Pollack VE (1976) Thromboembolic disease in renal allograft recipients. Arch Surg 111: 1086–1092
Rath CE, Mailliard JA, Schreiner GE (1957) Bleeding tendency in uremia. N Engl J Med 257:808–811
Ratnoff OD (1969) Epsilon aminocaproic acid-a dongerous weapon. N Engl J Med 280: 1124–1125
Reddy KNN, Kine DL (1980) Plasminogen activators. In: Kline DL, Reddy KNN (eds) Fibrinolysis. CRC Press, Boca Raton, pp 25–41
Reeve EB (1980) Steady state relations between factors X, Xa, II, IIa, antithrombin III and alpha-2 macroglobulin in thrombosis. Thromb Res 18: 19–31
Regoeczi E, Brain MC (1969) Organ distribution of fibrin in disseminated intravascular coagulation. Br J Haematol 17: 73–81
Reiner AP, Bell WR (1984) The fibrinolytic system in man. CRC Crit Rev Oncol Hematol 2: 33–81
Remmele W, Harms D (1968) Zur pathologischen Anatomie des Kreislaufschocks beim Menschen. Klin Wochenschr 46: 352–357
Remuzzi G, Bertani T, Mecca G, Donati MB, de Gaetano D (1978) Factor VIII- related protein on vascular intima of patients with chronic renal failure and prolonged bleeding times. Br Med J I: 70–72
Remuzzi G, Livio M, Marchiaro G, Mecca G, de Gaetano G (1978) Bleeding in renal failure, altered platelet function in chronic uraemia only partially corrected by haemodialysis. Nephron 22: 347–353
Remuzzi G, Benigni A, Dodesini P et al. (1982) Platelet function in patients on maintenance hemodialysis depressed or enhanced? Clin Nephrol 17: 60–63
Remuzzi G, Benigni A, Dodesini P et al. (1983) Reduced platelet thromboxane formation in uremia. J Clin Invest 71: 762–768
Ribes EA, Domenech JC, Nicolas JMM, Gaspar ML (1975) Risk of acute renal failure associated with disseminated intravascular coagulation. Br Med J 3: 745
Rick ME, Hoyer LW (1977) Thrombin activation of factor VIII: the effect of inhibitors. Br J Haematol 36: 585–597
Riesmann D (1907) Hemorrhages in the course of Blight’s disease with especial reference to the occurence of a hemorrhagic diathesis of nephrotic origin. Am J Med Sci 134: 709–714
Rondeau E, Angles-Cano E, Delarue F, Sultan Y, Sraer JD (1986) Polyunsaturated fatty acids increase fibrinolytic activity of human isolated glomeruli. Kidney Int 30: 701–705
Rosenberg JC, Broersma RJ, Bullemer G, Mammen EF, Lenagham R, Rosenberg BF (1969) Relationship of platelets, blood coagulation, and fibrinolysis to hyperacute rejection of renal xenografts. Transplantation 8: 152–161
Rosenberg RD (1975) Actions and interactions of antithrombin and heparin. N Engl J Med 292: 146–151
Rothberger H, Barringer M, Meredith J (1984) Increased tissue factor activity of monocytes/macrophages isolated from canine renal allografts. Blood 63: 623–628
Rothberger H, Meredith J, Mutton T, Brown J, McGee MP (1985) Increased tissue factor activity generation in vitro by canine blood leukocytes associated with allogeneic kidney transplantation and rejection. Thromb Haemost 51: 1–4
Rowlands DT, Hill GS, Zmijewski CM (1976) The pathology of renal homograft rejection. Am J Pathol 85: 774–803
Ruggeri ZM, Gordon YB, Ardaillou N et al. (1979) Urinary excretion of factor VIII after renal transplantation. Br Med J I: 300–303
Sakariassen KS, Bolhuis PA, Sixma JJ (1979) Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-von Willebrand factor bound to the subendothelium. Nature 279: 636–638
Salaman JR (1970) Use of radioactive fibrinogen for detecting rejection of human renal transplants. Br Med J II: 517–521
Salaman JR (1972) A technique for detecting rejection episodes in human transplant recipients using radioactive fibrinogen. Br J Surg II: 138–142
Salzman EW, Neri LL (1966) Adhesiveness of blood platelets in uremia. Thromb Diath Haemorrh 15: 84–92
Sampol J, Robert A, Jahjah F, Gillet A, Olmer M (1982) Factor VIII related antigen, coagulation tests and acute renal failure. Proc Eur Dial Transplant Assoc Eur Ren Assoc 19: 325–328
Sanchez-Ibarrola A, Quazzaz S, Naish P (1981) Clearance of fibrin from glomeruli. Renal cortical fibrinolytic response after thromboplastin infusion in the rat. Clin Sci 60: 47–53
Scherf H, Nies AS, Schwertschlag U, Hughes M, Gerber JG (1986) Hemodynamic effects of platelet activating factor in the dog kidney in vivo. Hypertension 8: 737–741
Schipper HG, Roos JVD, Meulen F, ten Cate JW (1981) Antithrombin III deficiency in surgical intensive care patients. Thromb Res 21: 73–80
Schräder J, Rumpf KW (1984) Gerinnungs-Hämatologie. Nieren Hochdruckkr 13: 296–306
Schräder J, Scheler F (1985) Coagulation disorders in acute renal failure. In: Sieberth H-G, Mann H (eds) Continous arterio-venous hemofiltration. Karger, Basel, pp 25–36
Schräder J, Köstering H, Züchner C, Caumanns J, Scheler F (1983) Methoden zur Bestimmung des Antithrombin III. Ärztl Lab 29: 35–39
Schräder J, Gallimore MJ, Eisenhauer T, Brüggemann M, Redlin E, Köstering H, Scheler F (1985) Studies on components of the coagulation, plasma kallikrein and firbinolytic systems in renal transplant patients. Thromb Haemost 54: 253
Schräder J, Valentin R, Tönnes HJ et al. (1985) Low molecular weight heparin in hemodialysis and hemofiltration patients. Kidney Int 28: 823–829
Schräder J, Kandt M, Züchner C, Köstering H, Scheler F (1986) Comparison of unfractionated heparin and low molecular weight heparin during long term use in chronic haemodialysis and haemofiltration patients. Haemostasis [Suppl 2] 16: 48–58
Schräder J, Köstering H, Scheler F (1986) Bedeutung von Antithrombin III bei Nierenerkrankungen. Behring Inst Mitt 79: 216–230
Schräder J, Neuhaus KL, Tebbe U, Köstering H, Scheler F (1986) Fibrinolytic activity in renal venous blood in man. Klin Wochenschr 64: 587–589
Schräder J, Köstering H, Scheler F (1987) Hämostasestörungen bei Nierenerkrankungen. In: Mammen EF (Hrsg) Intensivmedizin aktuell. Medizinische Verlagsgesellschaft, Marburg, S 99–111
Schräder J, Stibbe W, Armstrong VW, Kandt M, Muche R, Köstering H, Seidel D, Scheler F (in press) Comparison of low molecular weight heparin to standard heparin in a randomized long-term study on haemodialysis/haemofiltration patients. Kidney Int
Schultze G, Heitz J, Krais T, Neumayer HH, Wagner K, Molzahn M (1984) The impact of eicosanoids on compliance, cardiovascular performance, and coagulation during hemodialysis. Biomed Biochim Acta 43: 426–429
Schuster HP, Long MW, Blair J, Sedensky JA, Mammen EF (1980) The influence of disseminated intravascular coagulation on renal function after experimental hemorrhagic shock. Resuscitation 8: 3–28
Schwartz BS, Levy GA, Curtiss LK, Fair DS, Edington TS (1981) Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro. Two procoagulant activities are produced by peripheral blood mononuclear cells. J Clin Invest 67: 1650–1658
Scott WL, Francis CW, Knutson DW, Marder VJ (1986) Specific indentification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation. J Lab Clin Med 107: 534–543
Scully MF, Kakkar W (1979) Chromogenic peptide substrates. Churchill Livingstone, Edinburgh London New York
Seitz R, Michalik R, Egbring R, Karges HE, Lange H (1984) Impaired fibrinolysis after kidney transplantation. Proc Eur Dial Transplant Assoc Eur Ren Assoc 21: 941–944
Seitz R, Michalik R, Karges HE, Lange H, Egbring R (1986) Impaired fibrinolysis and protein c increase after cadaver kidney transplantation. Thromb Res 42: 277–288
Shah BC, Ambrus JL, Mink IB, Albert DJ, Sampson D, Murphy GP (1972) Fibrin degradation products in renal parenchymal disease states and renal transplant patients. Transplantation 14: 705–710
Shakespeare M, Wolf P (1979) The demonstration of urokinase antigen in whole blood. Thromb Res 14: 825–835
Sharma HM, Moore S, Merrick HW, Smith MR (1972) Platelets in early hyperacute allograft rejection in kidneys and their modification by sulfinpyrazone (Anturan) therapy. Am J Pathol 66: 445–453
Sharma MSC, Saim MJS (1981) Platelet adhesiveness, plasma fibrinogen and fibrinolytic activity in hypertension. Thromb Haemost 45:100–108
Shelley WB, Juhlin L (1977) Induction of fibrin thrombi by monocytes. Nature 270:343–344
Shetty HG, Almeida A, Sheth SM, Chawla KP, Acharya VN (1982) Coagulation studies in uraemia. J Postgrad Med 28: 149–159
Shulman H, Striker G, Deeg HJ, Kennedy M, Strob R, Thomas ED (1981) Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation. N Engl J Med 305: 1392–1395
Sieberth HG, Kindler J, Vlaho M, Glöckner WM, Freiberg J, Pelzer R (1982) Langzeitergebnisse der chronisch-intermittierenden Dialysebehandlung. Med Welt 33: 1363–1366
Siefring GE, Castellino FJ (1975) De novo biosynthesis of plasminogen in the anephric rat. J Appl Physiol 38: 114–116
Siegal T, Seligsohn U, Aghai E, Modan M (1978) Clinical and laboratory aspects of disseminated intravascular coagulation (DIC): a study of 118 cases. Thromb Haemost 39: 122–134
Silberbauer KF, Wolf A, Stummvoll HK, Sinzinger H, Ring F, Pinggera WF (1979) Zirkulierende Thrombozytenaggregate während Hämodialyse. Klin Wochenschr 57: 1137–1138
Simon P, Ang KS, Cam G (1987) Enhanced platelet aggregation and membrane biocompatibility: possible influence on thrombosis and embolism in hemodialysis patients. Nephron 45: 172–173
Simpson KM, Bunch DL, Amemiya H et al. (1970) Humoral antibodies and coagulation mechanisms in the accelerated or hyperacute rejection of renal homografts in sensitized canine recipients. Surgery 68: 77–85
Sixma JJ, Sakariassen KS, Stel HV, Houdijk WPM (1984) Functional domains of von Willebrand factor. J Clin Invest 74: 736–744
Slapak M, Greenbaum M, Bardawil W, Saravis C, Joison J, McDermott WV (1971) Effect of heparin, arvin, liver perfusion, and heterologous antiplatelet serum on rejection of pig kidney by dog. Transplant Proc 3: 558–561
Smith N, Candler S, Hawker RJ, Hawker LM, Barnes AD (1979) Indium labelled autologous platelets as diagnostic aid after renal transplantation. Lancet II: 1241–1242
Smith-Erichsen N, Aasen AO (1984) Evaluation of severity and prognosis in early stages of septicemia by means of chromogenic peptide substrate assays. Eur Surg Res [Suppl 2] 16: 140–146
Smith-Erichsen N, Aasen AO, Gallimore M J, Amundsen E (1982) Studies of components of the coagulation systems in normal individuals and septic shock patients. Circ Shock 9: 491–497
Smokovitis A, Maier M, Binder BR (1984) Comparison between vascular plasminogen activator activity and changes in blood flow in the renal cortex in pigs. Thromb Haemost 51: 150–153
Smokovitis A, Wagner M, Starlinger M, Opitz A, Binder BR (1985) Changes in plasminogen activator activity and plasmin inhibitor in the pig during experimental hypovolaemia. Thromb Haemost 52: 130–133
Sobel GW, Möhler SR, Jones NW, Dowdy ABC, Guest MM (1952) Urokinase: an activator of plasma profibrinolysis extracted from urine. Am J Physiol 171: 768–769
Solez K, Morel-Maroger L, Sraer JD (1979) The morphology of „acute tubular necrosis“ in man: analysis of 57 renal biopsies and a comparison with the glycerol model. Medicine 58: 362–376
Soper WD, Pollak R, Manaligod JR, Hau T, Mozes MF, Jonasson O (1982) Use of anticoagulation in cadaver renal transplants. J Surg Res 32: 370–376
Spagnuolo PJ, Bass SH, Smith MC, Danviriyasup K, Dunn MJ (1982) Neutrophil adhesiveness during prostacyclin and heparin hemodialysis. Blood 60: 924–929
Spero JA, Lewis JH, Hasiba U (1980) Disseminated intravascular coagulation. Findings in 346 patients. Thromb Haemost 43: 28–33
Sraer JD, Delarue F, Dard S, De Seigneux R, Morel-Maroger L, Kanfer A (1975) Glomerular fibrinolytic activity after thrombin perfusion in the rat. Lab Invest 32: 515–517
Sraer JD, Blanc E, Delarue F, Kanfer A, Ardaillou R, Richet G (1979) Effect of calcium and hydrogen ion on the fibrinolytic activity of isolated renal glomeruli from rat. Kidney Int 15: 238–245
Stahl E, Gerdin B, Rammer L (1981) Protective effect of angiotensin II inhibition on acute renal failure after intravascular coagulation in the rat. Nephron 29: 250–257
Stahl E, Karlberg BE, Rammer L (1982) Fibrin deposition in the kidney and renal blood flow during intravascular coagulation in the rat: influence of the renin-angiotensin system. Clin Sei 62: 35–41
Stahl E, Boberg U, Larsson L, Rammer L, Persson AEG (1983) Effect of renal tubular obstruction on stop-flow pressure and glomerular deposition of fibrin during intravascular coagulation in the rat. Kidney Int 24: 323–329
Starzl TE, Lerner RA, Dixon FJ, Groth CG, Brettschneider L, Terasaki PI (1968) Shwartzman reaction after human renal homotransplantation. N Engl J Med 278: 642–648
Starzl TE, Boehmig HJ, Amemiya H et al.(1970) Clotting changes, including disseminated intravascular coagulation, during rapid renal-homograft rejection. N Engl J Med 283: 383–390
Stewart JH, Castaldi PA (1967) Uraemic bleeding: a reversible platelet defect corrected by dialysis. Q J Med 36: 409–423
Stewart JH, Farrell PC, Dixon M (1975) Reduction of platelet/fibrin deposition in haemodialysis by aspirin administration. Aust NZ J Med 5: 117–122
Sueishi K, Nanno S, Okamura T, Inoue S, Tanaka K (1982) Purification and characterization of human kidney plasminogen activators dissimilar to urokinase. Biochim Biophys Acta 717: 327–336
Sundsmo JS, Fair DS (1983) Relationships among the complement, kinin, coagulation and fibrinolytic systems in the inflammatory reaction. Clin Physiol Biochem 1: 225–284
Swartz RD (1981) Hemorrhage during high-risk hemodialysis using controlled heparinization. Nephron 28: 65–69
Swartz RD, Port FK (1979) Preventing hemorrhage in high-risk hemodialysis: regional versus low-dose heparin. Kidney Int 16: 513–518
Szczeklik A, Kopec M, Sladek K, Musial J, Chmielewska J (1983) Prostacyclin and the fibrinolytic system in ischemic vascular disease. Thromb Res 29: 655–660
Taenaka N, Shimada Y, Hirata T, Nishijima M, Yoshiya I (1982) New approach to regional anticoagulation in hemodialysis using gabexate mesilate (Foy). Crit Care Med 10: 773–775
Takemoto Y, Tanabe J, Tanaka S, Fukuda A, Fujii C, Kohama A, Shibata S (1985) The effect of prophylactic heparinization on DIC arising from transitory circulatory arrest in dogs. Circ Shock 15: 131–139
Teien AN, Li M, Abildgaard U (1976) Assay of heparin in plasma using a chromogenic substrate for activated factor X. Thromb Res 8: 413–416
Terada Y, Ueno A (1983) Hyperacute renal allograft rejection in the rabbit. Transplantation 35: 205–208
Terao T, Kobayashi T (1983) The role of placental urokinase inhibitor in toxemia of pregnancy. Biol Res Pregnancy 4: 145–151
Thaler E, Lechner K (1981) Antithrombin III deficiency and thromboembolism. Clin Haematol 10: 369–390
Theiss W, Graeff H, Bleyl U, Immich H, Kuhn W (1970) Reversible Stadien intra-vaskularer Gerinnung und ihre Auswirkungen auf Nierenfunktion und Urokina-seausscheidung. Thromb Diath Haemorrh 23: 369–385
Thiagarajan P, Niemetz J (1980) Procoagulant tissue factor activity of circulating peripheral blood leukocytes. Results of in vivo studies. Thromb Res 17: 891–896
Thomson AW, Webster LM, Aldridge RD, Morrice LM (1985) Cyclosporin and leucocyte procoagulant activity. Lancet I: 1396
Timor-Tritsch I, Better OS, Tatarsky I, Chaimowitz C, Peretz A, Abramovici H (1970) Successful treatment of post-partum renal failure with heparin. Br Med J 4: 221–222
Todd AS, Hargreaves LN (1975) Identification of plasminogen activator in tissues. Prog Chem Fibrin Thromb 1: 217–224
Tracy PB, Rohrbach MS, Mann KG (1983) Functional prothrombinase complex assembly on isolated monocytes and lymphocytes. J Biol Chem 258: 7264–7267
Triantaphyllopoulos DC (1984) Effects of human antithrombin III on mortality and blood coagulation induced in rabbits by endotoxin. Thromb Haemost 51: 232–235
Triantaphyllopoulos DC, Cho MS (1986) Effect of injection of CI inactivator on the platelet count and blood coagulation in rabbits infused with endotoxin. Thromb Haemost 55: 293
Tsao BP, Fair DS, Curtiss LK, Edington TS (1984) Monocytes can be induced by lipopolysaccharide-triggered T lymphocytes to express functional factor VH/VIIa protease activity. J Exp Med 159: 1042–1049
Tuddenham EGD, Lazarchick J, Hoyer LW (1981) Synthesis and release of factor VIII by cultured human endothelial cells. Br J Haematol 47: 617–626
Turney JH, Woods HF, Fewell MR, Weston MJ (1981) Factor VIII complex in uraemia and effects of haemodialysis. Br Med J II: 1653–1656
Turney JH, Fewell M, Williams LC, Dodd N, Weston MJ (1982) Paradoxical behaviour of antithrombin III during hemodialysis and its prevention with prostacyclin. Clin Nephrol 17: 31–35
Vaage J (1982) Prediction of prognosis in intensive care patients. Acta Chir Scand [Suppl] 509: 73–75
Vanrenterghem Y, Lernt T, Roels L et al.(1985) Thromboembolic complications and haemostatic changes in cyclosporin-treated cadaveric kidney allograft recipients. Lancet I: 999–1002
Vassalli P, McCluskey RT (1965) The coagulation process and glomerular disease. Am J Med 39: 179–183
Vaziri ND, Toohey J, Paule P, Alikhani S, Hung E (1984) Coagulation abnormalities in patients with end-stage renal disease treated with hemodialysis. Int J Artif Organs 7: 323–326
Viener A, Aviram M, Better OS, Brook JG (1986) Enhanced in vitro platelet aggregation in hemodialysis patients. Nephron 43: 139–143
Vinazzer H (1986) Substitution of antithrombin III in shock and DIC. In: Böttiger LE (eds) Antithrombin deficiency. KabiVitrum, Stockholm pp 79–83
Vinazzer H, Blauhut B, Bergmann H (1984) Die Antithrombin Ill-Substitution bei Patienten im Schock. Folia Haematol 111: 806–816
Vygovskaya YI, Vorobel AV, Buzherak NF (1983) Kallikrein-kinin system of blood plasma in heterotransfusion backed by the use of heparin. Folia Haematol 110: 716–724
Wachtfogel YT, Kucich U, James HL et al. (1983) Human plasma kallikrein releases neutrophil elastase during blood coagulation. J Clin Invest 72: 1672–1677
Wardle EN (1973) Intravascular coagulation in experimental acute renal failure. Thromb Diath Haemorrh 29: 579–591
Wardle EN (1974) Fibrin in renal disease: functional considerations. Clin Nephrol 2: 85–92
Wardle EN (1976) The functional role of intravscular coagulation in renal disease. Scott Med J 21: 83–91
Wardle EN, Uldall PR (1972) Effect of heparin on renal function in patients with oliguria. Br Med J 4: 135–138
Wardle EN, Uldall PR, Swinney JS (1974) Radio-fibrinogen catabolism studies in human renal allograft recipients. Transplantation 18: 508–514
Warrell RP, Hultin ME, Coller BS (1979) Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in renal failure. Am J Med 66: 226–228
Watson AJS, Keogh JAB (1982) Effect of l-deamino-8-d-arginine vasopressin on the prolonged bleeding time in chronic renal failure. Nephron 32: 49–52
Wegmüller E, Grüninger U, Furlan M, Beck EA, Hodler J, Reubi FC (1981) Factor VIII activity in chronic renal disease. Nephron 28: 157–162
Weinstein MJ, Chute LE, Schmitt GW et al.(1985) Abnormal factor VIII coagulant antigen in patients with renal dysfunction and in those with disseminated intravascular coagulation. J Clin Invest 76: 1406–1411
Wessel-Aas T, Blomhoff JP, Wirum E, Nilsen T (1984) Hemodialysis and cell toxicity in vitro related to plasma triglycerides, post-heparin lipolytic activity and free fatty acids. Acta Med Scand 216: 75–83
Whitaker AN (1974) Acute renal failure in disseminated intravascular coagulation. Prog Biochem Pharmacol 9: 45–64
Whitaker AN, McKay DG, Csavossy J (1969) Studies of catecholamine shock. Am J Pathol 56: 153–179
Whitaker AN, Bunce IH, Nicoll P, Dowling SV (1973) Interaction of angiotensin with disseminated intravascular coagulation. Am J Pathol 72: 1–10
Whitaker AN, Bunce IH, Nicoll P, Emmerson BT (1973) Disseminated intravascular coagulation and intravascular hemolysis in glomerular disease. Perspect Nephrol Hypertens 2: 845–870
Whitfield LR, Levy G (1983) Pharmacokinetics of heparin V: in vivo and in vitro factors affecting the relationship between concentration and anticoagulant effect of heparin in rat plasma. J Pharm Sci 72: 1141–1146
Wieding JU, Merten HA, Köstering H (1984) Modifizierte Fibrinmonomerkomplex-Bestimmung zur raschen und zuverlässigen Diagnostik von Umsatzsteigerungen im Gerinnungssystem. In: Beck EA (Hrsg) Thrombose- und Hämostaseforschung 1984. Schattauer, Stuttgart, S 397–398
Wijngaards G, Kluft C, Groeneveld E (1982) Demonstration of urokinase-related fibrinolytic activity in human plasma. Br J Haematol 51: 165–169
Wijngaards G, Rijken DC, Wezel AL van, Groeneveld E, Velden CAM van der (1986) Characterization and fibrin-binding properties of different molecular forms of pro-urokinase from a monkey kidney cell culture. Thromb Res 42: 749–760
Wilhelmsson S, Asaba H, Gunnarsson B, Kudryk B, Robinson D, Bergström J (1981) Measurement of fibrinopeptide A in the evaluation of heparin activity and fibrin formation during hemodialysis. Clin Nephrol 15: 252–258
Winchester JF, Gelfand MC, Foegh ML, Hellrich GB, Schreiner GE (1983) Early indicators of renal allograft rejection. Kidney Int [Suppl 14] 23: 34–40
Winkelmann G, Meyer G, Roskamm H (1986) Der Einfluß körperlicher Belastung auf Blutgerinnung und Fibrinolyse bei untrainierten Personen und Hochleistungssportlern. Klin Wochenschr 13: 712–716
Winter M, Needham J, Mackie J, Cameron JS (1984) Impaired vessel wall response to venous occlusion in patients with chronic renal failure on maintenance hemodialysis. Clin Nephrol 22: 307–313
Woo KT (1985) Platelet injury and antithrombin III in clinical nephrology. Ann Acad Med 14: 394–403
Woo KT, Lee EJC, Lau YK, Lim CH (1985) Antithrombin III in renal transplant recipients. Thromb Res 38: 201–206
Woo KT, Wei SS, Lee EJC, Lau YK, Lim CH (1985) Effects of hemodialysis and peritoneal dialysis on antithrombin III and platelets. Nephron 40: 25–28
Woods HF, Weston MJ, Bunting S (1978) Haemodialysis without heparin. Proc Eur Dial Transplant Assoc Eur Ren Assoc 15: 122–129
Wun TC, Schleuning WD, Reid E (1982) Isolation and characterization of urokinase from human plasma. J Biol Chem 257: 3276–3283
Ygge J (1970) Changes in blood coagulation and fibrinolysis during the postoperative period. Am J Surg 119: 225–232
Zaugg H (1980) Thromboplastic activity of human arterial walls and its interaction with the plasmatic coagulation system. J Clin Chem Clin Biochem 18: 545–549
Zazgornik J, Balcke P, Schmidt P, Kopsa H, Hysek H, Lenz K (1981) Alpha- 1-Antitrypsin und Fibrinogenspiegel bei chronischer Niereninsuffizienz und nach Nierentransplantation. Klin Wochenschr 59: 1261–1265
Zimmerman SW (1986) Chronic peritoneal dialysis is associated with progressive thrombocytosis. Peritoneal Dial Bull 6: 71–73
Zühlke V, Quellhorst E, Hierholzer E, Mietzsch G (1972) Disseminierte intravasculäre Gerinnung nach allogener Nierentransplantation. Diagnostische Bedeutung und therapeutische Konsequenzen. Klin Wochenschr 50: 370–378
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schrader, J. (1989). Literatur. In: Niere und Blutgerinnung. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74972-8_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-74972-8_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-51502-9
Online ISBN: 978-3-642-74972-8
eBook Packages: Springer Book Archive